Study on the Safety and Effectiveness of Delandistrogene Moxeparvovec for Patients with Duchenne Muscular Dystrophy
BelgiumStudy on the Safety of ATA-200 Gene Therapy for Patients with Limb-Girdle Muscular Dystrophy Type R5
FranceStudy on the Safety and Effectiveness of Filgotinib for Patients with Refractory Behcet's Disease, Idiopathic Inflammatory Myopathies, and IgG4-Related Disease
The NetherlandsStudy on the Effects of Human Normal Immunoglobulin in Adults with Dermatomyositis
BelgiumPhase 2 Study of Daxdilimab with Prednisone in Adults with Inadequately Controlled Dermatomyositis or Anti‑Synthetase Inflammatory Myositis
CzechiaA study testing brepocitinib compared to placebo for adults with dermatomyositis to see if it works and is safe
BelgiumStudy of SAT-3247 Compared to Placebo for Patients with Duchenne Muscular Dystrophy Who Can Walk
BelgiumA Study of Cizutamig for Patients with Severe Autoimmune Inflammatory Diseases That Did Not Respond to Previous Treatments
GermanyStudy of BMN 351 given by intravenous infusion to evaluate safety and tolerability in patients with Duchenne Muscular Dystrophy
ItalyTitle: Long-term safety and effectiveness study of ulviprubart in patients with inclusion body myositis who completed previous treatment
BelgiumStudy on Metoprolol for Preventing Heart Disease in Boys with Duchenne Muscular Dystrophy Aged 8-17
PolandStudy on the Effects of Casimersen and Golodirsen for Patients with Duchenne Muscular Dystrophy Amenable to Exon 45 or 53 Skipping
Belgiumpowered by
